NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,084 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,431,075 | +4.0% | 1,221,589 | +3.1% | 0.01% | +10.0% |
| Q2 2023 | $119,610,690 | -41.4% | 1,185,320 | -46.6% | 0.01% | +11.1% |
| Q1 2023 | $204,094,168 | +75.4% | 2,218,414 | +72.9% | 0.01% | -25.0% |
| Q4 2022 | $116,371,776 | +6.6% | 1,282,757 | -10.7% | 0.01% | +9.1% |
| Q3 2022 | $109,132,000 | -8.6% | 1,435,751 | +1.6% | 0.01% | -8.3% |
| Q2 2022 | $119,417,000 | +1.4% | 1,412,717 | +5.2% | 0.01% | +33.3% |
| Q1 2022 | $117,812,000 | +14.1% | 1,342,581 | +13.8% | 0.01% | +12.5% |
| Q4 2021 | $103,229,000 | +13.9% | 1,180,173 | +6.5% | 0.01% | +14.3% |
| Q3 2021 | $90,647,000 | -21.5% | 1,108,420 | -12.5% | 0.01% | -22.2% |
| Q2 2021 | $115,528,000 | +16.1% | 1,266,203 | +8.8% | 0.01% | +12.5% |
| Q1 2021 | $99,504,000 | -19.9% | 1,164,072 | -11.6% | 0.01% | -27.3% |
| Q4 2020 | $124,280,000 | +19.5% | 1,316,122 | +10.0% | 0.01% | 0.0% |
| Q3 2020 | $103,999,000 | +20.1% | 1,195,941 | +20.6% | 0.01% | +10.0% |
| Q2 2020 | $86,620,000 | -22.3% | 991,761 | -26.7% | 0.01% | -33.3% |
| Q1 2020 | $111,498,000 | -80.4% | 1,352,300 | -77.5% | 0.02% | -76.2% |
| Q4 2019 | $569,360,000 | -0.8% | 6,012,889 | -9.0% | 0.06% | -8.7% |
| Q3 2019 | $573,921,000 | -13.6% | 6,604,389 | -9.2% | 0.07% | -11.5% |
| Q2 2019 | $664,330,000 | -20.4% | 7,275,541 | -16.2% | 0.08% | -22.0% |
| Q1 2019 | $834,356,000 | +38.6% | 8,678,552 | +23.7% | 0.10% | +22.0% |
| Q4 2018 | $602,046,000 | +439.4% | 7,016,047 | +441.6% | 0.08% | +530.8% |
| Q3 2018 | $111,611,000 | +25.3% | 1,295,397 | +9.9% | 0.01% | +30.0% |
| Q2 2018 | $89,057,000 | -20.8% | 1,178,943 | -15.2% | 0.01% | -23.1% |
| Q1 2018 | $112,421,000 | -3.6% | 1,390,481 | +0.1% | 0.01% | -7.1% |
| Q4 2017 | $116,629,000 | -45.4% | 1,389,108 | -44.2% | 0.01% | -46.2% |
| Q3 2017 | $213,546,000 | +11.5% | 2,487,424 | +8.4% | 0.03% | +8.3% |
| Q2 2017 | $191,546,000 | +205.8% | 2,294,782 | +172.1% | 0.02% | +200.0% |
| Q1 2017 | $62,636,000 | +2.4% | 843,341 | +0.4% | 0.01% | 0.0% |
| Q4 2016 | $61,173,000 | -23.2% | 839,817 | -16.7% | 0.01% | -27.3% |
| Q3 2016 | $79,610,000 | -20.2% | 1,008,229 | -16.6% | 0.01% | -21.4% |
| Q2 2016 | $99,704,000 | +88.6% | 1,208,384 | +65.6% | 0.01% | +100.0% |
| Q1 2016 | $52,860,000 | -40.8% | 729,705 | -29.6% | 0.01% | -41.7% |
| Q4 2015 | $89,233,000 | -31.2% | 1,037,115 | -26.5% | 0.01% | -33.3% |
| Q3 2015 | $129,670,000 | -75.7% | 1,410,688 | -74.0% | 0.02% | -73.5% |
| Q2 2015 | $532,747,000 | +21.6% | 5,417,398 | +21.9% | 0.07% | +21.4% |
| Q1 2015 | $438,177,000 | +75.7% | 4,443,532 | +65.1% | 0.06% | +75.0% |
| Q4 2014 | $249,411,000 | +4.9% | 2,691,681 | +6.6% | 0.03% | 0.0% |
| Q3 2014 | $237,769,000 | -6.9% | 2,525,964 | -10.4% | 0.03% | -5.9% |
| Q2 2014 | $255,357,000 | +1.0% | 2,820,687 | -5.1% | 0.03% | -2.9% |
| Q1 2014 | $252,755,000 | +23.2% | 2,972,876 | +16.4% | 0.04% | +20.7% |
| Q4 2013 | $205,209,000 | +46.6% | 2,552,992 | +39.9% | 0.03% | +38.1% |
| Q3 2013 | $139,981,000 | +10.9% | 1,824,820 | +2.2% | 0.02% | 0.0% |
| Q2 2013 | $126,215,000 | – | 1,784,962 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |